ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Bo-Sch Group
The bioelectronics team at Bosch Healthcare solutions is developing new technologies in molecular diagnostics, focusing on the synthesis and characterization of electroactive biomolecules. They are seeking a PhD candidate in Organic Chemistry with expertise in organic synthesis and biomolecular modification. The intern position involves working closely with engineers and scientists on innovative healthcare solutions.
Bo-Sch Group is a Netherlands-based specialist in fastening technology, supplying a full range of fastening products including screws, nuts, CNC-turned parts, and cold-formed components. The company is a trusted automotive supplier with extensive experience in engineering and product development. Bo-Sch Group serves industrial and automotive customers with a focus on quality, precision, and innovative connection solutions.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Bo-Sch Group.
96% below the average for this role
Sr. Scientist/Staff Scientist: Nucleotide and Nucleic Acid Chemistry
Atlas Data Storage
Bench Scientist
Artech
Research Associate Organic Chemistry
Lonza
Adjunct Researcher - Physics & Astronomy - Rob Davis Research Lab
Brigham Young University
Research Associate Organic Chemistry
Lonza
Senior Scientist Chemistry (m/f/d) in Chemistry R&D Diagnostics with focus on Oligonucleotide synthesis
Roche